Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Source :: PR Newswire. June 27, 2024
Publication Year :: 2024
Abstract: NEW YORK, June 27, 2024 /PRNewswire/ -- The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according to Technavio. [...]

Subjects :: ADC Therapeutics S.A. -- Forecasts and trends
Amgen Inc. -- Forecasts and trends
Bayer AG -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Biological products industry -- Forecasts and trends
Patient compliance -- Forecasts and trends
Biotechnology industry -- Forecasts and trends
Lymphomas -- Forecasts and trends
Vincristine -- Forecasts and trends -- Market size
Radiotherapy -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools